Unichem gets USFDA nod for hypertension drug
Drug maker Unichem Laboratories today said it has received approval from the US health regulator to market Valsartan tablets, a hypertension drug.
The company has received approval from the US Food and Drug Administration (USFDA) to market the product, Unichem Laboratories said in a regulatory filing.
The company's product is the generic version of Novartis Pharmaceuticals Corp's Diovanb tablets and is indicated for lowering the blood pressure.
The product will be commercialised from the company's Ghaziabad plant, it added.
Shares of Unichem Laboratories today ended 0.23 down at Rs 279.30 on the BSE.
Disclaimer: No Business Standard Journalist was involved in creation of this content
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: May 07 2018 | 5:00 PM IST